BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

DiObex, Inc. 

600 Townsend Street, Suite 271

San Francisco  California  94103  U.S.A.
Phone: 415-551-0400 Fax: 415-551-4113


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Drug Company DiObex, Inc. Shutting Down 4/8/2009 8:26:34 AM
DiObex, Inc. to Present at 2008 Biotechnology Industry Organization (BIO) International Convention 6/12/2008 10:18:33 AM
DiObex, Inc. to Present at Canaccord Adams Diabetes and Obesity Conference 6/4/2008 12:21:33 PM
DiObex, Inc. Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics 4/1/2008 7:13:26 AM
DiObex, Inc. and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release 3/18/2008 7:10:38 AM
DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia Patent Protects Very Low Dose Glucagon 1/8/2008 7:35:04 AM
DiObex, Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 10/25/2007 10:05:06 AM
DiObex, Inc. to Present at Biotechnology Industry Organization (BIO) Investor Forum 2007 10/2/2007 10:28:18 AM
DiObex, Inc. Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 9/26/2007 7:32:30 AM
DiObex, Inc. to Present at Biotechnology Industry Organization (BIO) Mid-America Venture Forum 9/18/2007 8:12:40 AM
12